STAT3 inhibitors for cancer therapy: Have all roads been explored?

por Fagard, Remi, Metelev, Valeri, Souissi, Inès, Baran-Marszak, Fanny
Publicado 2013

Cellular response to alkylating agent MNNG is impaired in STAT1‐deficients cells

por Ah‐Koon, Laurent, Lesage, Denis, Lemadre, Elodie, Souissi, Inès, Fagard, Remi, Varin‐Blank, Nadine, Fabre, Emmanuelle E., Schischmanoff, Olivier
Publicado 2016

A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line

por Souissi, Inès, Ladam, Patrick, Cognet, Jean AH, Le Coquil, Stéphanie, Varin-Blank, Nadine, Baran-Marszak, Fanny, Metelev, Valeri, Fagard, Remi
Publicado 2012

A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κB

por Souissi, Inès, Najjar, Imen, Ah-Koon, Laurent, Schischmanoff, Pierre Olivier, Lesage, Denis, Le Coquil, Stéphanie, Roger, Claudine, Dusanter-Fourt, Isabelle, Varin-Blank, Nadine, Cao, An, Metelev, Valeri, Baran-Marszak, Fanny, Fagard, Remi
Publicado 2011